LEERINK PARTNERS
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital markets and investment objectives. They partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare.
LEERINK PARTNERS
Industry:
Banking Health Care
Founded:
1995-01-01
Status:
Active
Contact:
(800) 808-7525
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SSL By Default Font Awesome Apache ReCAPTCHA Microsoft GoDaddy SSL Gravity Forms IIS 8 ASP.NET Ajax Google Maps For Work
Similar Organizations
Accelerator Group
Accelerator Group is an investment banking Advisory services and Knowledge Services firm.
Macquarie Group
Macquarie Group is a global provider of banking, financial, advisory, investment and funds management services.
Moda Health
Moda Health offers quality health coverage in Oregon, Washington, and Alaska.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lovell Minnick Partners
Lovell Minnick Partners investment in Private Equity Round - Leerink Partners
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-08-26 | Kinnate Biopharma | Leerink Partners investment in Series C - Kinnate Biopharma | 98 M USD |
| 2019-05-23 | AlloVir | Leerink Partners investment in Series B - AlloVir | 120 M USD |
| 2018-09-05 | Fulcrum Therapeutics | Leerink Partners investment in Series B - Fulcrum Therapeutics | 80 M USD |
| 2018-06-08 | Precision BioSciences | Leerink Partners investment in Series B - Precision BioSciences | 110 M USD |
| 2018-05-16 | FogPharma | Leerink Partners investment in Series B - FogPharma | 66 M USD |
| 2018-02-27 | Generation Bio | Leerink Partners investment in Series B - Generation Bio | 100 M USD |
| 2018-02-01 | Avrobio | Leerink Partners investment in Series B - Avrobio | 60 M USD |
| 2017-11-13 | Arcus Biosciences | Leerink Partners investment in Series C - Arcus Biosciences | 107 M USD |
| 2017-09-08 | Replimune Group | Leerink Partners investment in Series B - Replimune Group | 55 M USD |
| 2017-03-30 | Solid Biosciences | Leerink Partners investment in Series C - Solid Biosciences | 50 M USD |
Newest Events participated
Participated in 3rd Annual NEVY Awards
on 2015-05-13 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer |
More informations about "Leerink Partners"
The Healthcare Investment Bank - Leerink Partners
Leerink Partners is an investment bank uniquely dedicated to serving innovation-driven and growth-minded healthcare companies. Search. Investment Banking Institutional Equities. Equity Research. Deep Healthcare Coverage and …See details»
Firm - Leerink Partners
Leerink founded Leerink Capital Partners in 2013, a healthcare-focused, multi-strategy asset management firm, and in 2019, its private equity funds were integrated into SVB Capital. In …See details»
Leerink Partners - The Org
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and …See details»
Leerink Partners - Leadership Team - The Org
The Leadership Team at Leerink Partners drives the strategic vision and operational effectiveness of the firm, leveraging their extensive expertise in healthcare investment banking. This diverse …See details»
Leerink Partners - Crunchbase Investor Profile & Investments
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital …See details»
Leerink Partners Org Chart + Executive Team - The …
The organizational chart of Leerink Partners displays its 30 main executives including Jeffrey Leerink, Tom Davidson and Jim KellySee details»
Leerink Partners: The Story of One of Boston’s Prominent …
Nov 20, 2023 In 2021, Leerink Partners strengthened its focus on the healthcare industry with key hires, including Barry Blake as Global Co-Head of Investment Banking. This move, …See details»
Equity Research | Leerink Partners
Prior to joining Leerink Partners in 2015, Mr. Kelly worked at Credit Suisse, where he served in research management as an Associate Director of Equity Research in New York and was …See details»
Leerink Partners - Wikiwand
Leerink Partners was founded in 1995 as Leerink Swann LLC. [2] [4] The following year, the bank established MEDACorp expert network as a joint venture with Dr. Dan Dubin. [2] It acted as a …See details»
Leerink Partners Company Profile: Service Breakdown & Team
Leerink Partners General Information Description. Founded in 1995, Leerink Partners is an investment banking firm headquartered in Boston, Massachusetts. The firm provides services …See details»
Leerink Partners - Contacts, Employees, Board Members
Leerink Partners has 9 board members and advisors, including William Rastetter. William Rastetter Advisor. Richard N. Pallan Board Member. Michael Stansky Board Member Jun 14, …See details»
Leerink Partners - Overview, News & Similar companies - ZoomInfo
Jan 4, 2024 Who is Leerink Partners. Leerink Partners LLC is a leading investment bank, specializing in healthcare and life sciences. Our knowledge, experience and focus enable us …See details»
Leerink Partners LLC Company Profile - Dun & Bradstreet
Leerink Swann also provides investment advisory services to life sciences companies, medical professionals, and high-net-worth investors. In January 2019, Leerink Holdings, …See details»
Leerink Partners Company Profile - Office Locations ... - Craft
Leerink Partners (also known as SVB Securities) is an investment bank specializing in healthcare. It partners with companies that develop and commercialize innovative products and services …See details»
Leerink Partnrs Lifts Earnings Estimates for HCA Healthcare
17 hours ago Tidemark LLC purchased a new position in HCA Healthcare in the 4th quarter valued at $36,000. Finally, ORG Partners LLC lifted its holdings in HCA Healthcare by 344.0% …See details»
NeoGenomics (NASDAQ:NEO) Rating Lowered to "Market …
17 hours ago NeoGenomics (NASDAQ:NEO - Get Free Report) was downgraded by equities researchers at Leerink Partners from an "outperform" rating to a "market perform" rating in a …See details»
Leerink Partners Downgrades NeoGenomics (BMV:NEO) - Nasdaq
2 days ago Leerink Partners Downgrades NeoGenomics (BMV:NEO) April 30, 2025 — 01:01 pm EDT. Written by George Maybach for Fintel-> Fintel reports that on April 30, 2025, Leerink …See details»
Leerink Partners Initiates Coverage of Akebia Therapeutics
Apr 24, 2025 Fintel reports that on April 28, 2025, Leerink Partners initiated coverage of Akebia Therapeutics (NasdaqCM:AKBA) with a Outperform recommendation. As of April 24, 2025, the …See details»
Leerink Partners - Equity Research Team - The Org
The Equity Research Team at Leerink Partners specializes in analyzing market trends, financial data, and company performance within the healthcare industry to provide in-depth research …See details»
Akebia Therapeutics (NASDAQ:AKBA) Coverage Initiated by …
4 days ago Equities research analysts at Leerink Partners began coverage on shares of Akebia Therapeutics (NASDAQ:AKBA - Get Free Report) in a report released on Monday,Benzinga …See details»